Newsroom | NeoGenomics Laboratories

July 28, 2020

NeoGenomics Reports Revenue of $87 Million in the Second Quarter amid COVID-19 Pandemic

Press Release

July 20, 2020

NeoGenomics Announces Board Appointments

Press Release

July 14, 2020

Liquid Biopsy Testing for PIK3CA Mutation

Blog

July 1, 2020

NeoGenomics Schedules its Second Quarter Earnings Release for July 28, 2020

Press Release

June 29, 2020

NeoGenomics Launches Comprehensive Suite of Solid Tumor Liquid Biopsy Tests for Cancer Patients

Press Release

June 29, 2020

NeoGenomics To Virtually Present At The Raymond James Human Health Innovation Conference

Press Release

June 23, 2020

A spotlight on CDx development

Blog

June 22, 2020

ctDNA detection in early-stage non-small cell lung cancer

Literature

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients